7 Results for "

BET BD2-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "BET BD2-IN-1" in MCE Product Catalog:

Cat. No.: HY-155680
CAS No.: 2677039-24-4
Research Areas:  

Inflammation/Immunology

BET BD2-IN-1 (compound 45) is a potent and selective inhibitor of BET BD2 (IC50=1.6 nM). BET BD2-IN-1 inhibits the differentiation of Th17 cells by decreasing the activation of STAT3 and NF-κB. BET BD2-IN-1 is used in psoriasis and inflammatory bowel disease (IBD) research .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-16652
CAS No.: 1044870-39-4
Synonyms: RVX-208; RVX000222
Research Areas:  

Cancer

Apabetalone (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively .
loading...
    loading...
Cat. No.: HY-114416
CAS No.: 1637770-13-8
Purity:  99.80%
Research Areas:  

Cancer

GS-626510 is a potent, and orally active BET family bromodomains inhibitor, with Kd values of 0.59-3.2 nM for BRD2/3/4, with IC50 values of 83 nM and 78 nM foe BD1 and BD2, respectively .
loading...
    loading...
Cat. No.: HY-16652R
CAS No.: 1044870-39-4
Synonyms: RVX-208 (Standard); RVX000222 (Standard)
Research Areas:  

Cancer

Apabetalone (Standard) is the analytical standard of Apabetalone. This product is intended for research and analytical applications. Apabetalone (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively .
loading...
    loading...
Cat. No.: HY-129201
CAS No.: 1616400-50-0
Purity:  99.51%
Research Areas:  

Cancer

ZEN-2759 is a potent BET (Bromodomain and Extra-Terminal Domain) inhibitor, with IC50 values of 0.23, 0.08 and 0.28 μM for BRD4(BD1), BRD4(BD2), and BRD4(BD1BD2), respectively .
loading...
    loading...
Cat. No.: HY-173315
Research Areas:  

Cancer

pan-BET/BD2-IN-1 (compound 6b) is a selective extra-terminal (BET) protein inhibitor (BRDT-1 Ki = 1.05 μM and BRD4-1 Ki = 0.68 μM). pan-BET/BD2-IN-1 inhibits MM.1S cancer cell growth with an IC50 of 2.6 μM .
loading...
    loading...
Cat. No.: HY-155809
Research Areas:  

Cancer

BET-IN-17 (compound 16) is a pan-inhibitor of BET with pIC50s of 7.8 and 7.6 for BET BD1 and BET BD2, respectively .
loading...
    loading...